SEARCH RESULTS FOR: "Tag: BIIB"
loading image
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(3)
ARTICLES/BLOGS
2021(5)
2020(5)
2019(16)
2018(11)
2017(19)
2016(20)
2015(23)
2014(3)
CATEGORIES
5-Minute Market Rundown(5)
Analyst Downgrades(4)
Analyst Update(16)
Analyst Upgrades(5)
Buzz Stocks(29)
By the Numbers(4)
Earnings Preview(3)
Expectational Analysis(2)
Ezines(2)
General(14)
Intraday Option Activity(14)
Market Recap(1)
Midday Market Check(5)
Opening View(7)
Quantitative Analysis(2)
Stock Market News(5)
Stocks On the Move(12)
Technical Analysis(1)

6/18/2021 3:28 PM
This week was packed with not so sunny news, though a bright spot did shine through on Monday, as the S&P 500 and Nasdaq both scored record highs. Meanwhile, the Dow logged a small loss as investor...
6/11/2021 1:58 PM
This week saw plenty of action, not only from the major benchmarks, but also from retail investors who set their sights on a number of heavily shorted stocks. Kicking off the week, the Dow extended...
6/11/2021 10:13 AM
The shares of Biogen Inc (NASDAQ:BIIB) are up 1.5% at $421 this morning, following a slew of analyst bull notes, including a hefty price-target hike from J.P. Morgan Securities to $435 from $269, as ...
4/22/2021 9:57 AM
The shares of Biogen Inc (NASDAQ:BIIB) were last seen down 3.9% at $259.23, even after the pharmaceutical concern posted first-quarter earnings of $5.34 per share, which topped analysts' estimates. T...
1/29/2021 10:24 AM
Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is up 7.9% to trade at $291.00 this morning, after the Food and Drug Administration (FDA) extended the review period for Biogen's experimental Alzhe...
 
Special Offers from Schaeffer's Trading Partners